The means by which epicardial adipose tissue (EAT) could influence coronary plaque progression biologically remain unclear. We investigated the association between the histological findings of EAT and coronary plaque characteristics assessed by coronary computed tomography angiography (CCTA). We enrolled 34 patients in whom one or more coronary plaques containing non-calcified components were detected on CCTA before cardiac surgery [coronary artery bypass graft (CABG) or non-CABG]. We evaluated visceral adipose tissue (VAT) area, EAT volume, and coronary plaque characteristics including minimum computed tomography density (CTD) and vascular Remodeling Index (RI). Lower CTD and higher RI were considered as high-risk characteristics, and coronary plaque with both CTD < 39 Hounsfield units and RI > 1.05 was defined as two-characteristic plaque (2-CP). The numbers of CD68 + macrophages and CD31 + microvessels were assessed in six random high-power fields (400×) of EAT samples obtained during cardiac surgery. The entire cohort showed a wide range of EAT volume, which were similar between patients with 2-CP and those without. Patients with 2-CP had more amounts of EAT macrophages (85 ± 38 versus 45 ± 22, p = 0.0005) and vascularity (62 ± 33 versus 37 ± 19, p = 0.013) than those without. On multivariate analyses adjusted for age, sex, coronary risk factors, statin use, type of surgery, VAT area, EAT volume, and coronary calcium score, the presence of 2-CP showed significant correlation with increased EAT macrophages (β = 0.65, p = 0.014) and vascularity (β = 0.74, p = 0.0053). Our findings support the hypothesis that EAT biologic activities are associated with coronary plaque vulnerability.
Introduction
Epicardial adipose tissue (EAT) generates various cytokines and mediators [1] [2] [3] , which may influence coronary arteries biologically. Epicardial adipose tissue shares its embryologic origin with visceral adipose tissue (VAT), which reportedly increases the risk of the metabolic syndrome through its endocrine functions [4] . As EAT is also considered an endocrine organ, it has been proposed that EAT plays an important role in the inflammatory aspects of coronary atherosclerosis.
Epicardial adipose tissue obtained from individuals with coronary artery disease (CAD) exhibits extensive inflammatory cell infiltrates, predominantly represented by macrophages [5] . Neoangiogenesis, the process of new blood vessel formations, is reported to be a rate-limiting step for adipose tissue expansion. Recent animal studies have 1 3 focused on the relationships between adventitia-associated angiogenesis, perivascular adipose tissue, and plaque development [6] . However, the means by which the inflammatory and angiogenic properties of EAT could influence coronary plaque progression in humans remain unclear.
As the high-risk characteristics of coronary plaques on coronary computed tomography angiography (CCTA), higher vascular Remodeling Index (RI) and lower computed tomography density (CTD) are suggested [7] , which predict major adverse cardiac events [8] . We previously reported that EAT inflammation and vascularity independently correlated with moderate coronary calcification and presence of coronary plaque containing non-calcified components on CCTA [9] .
To further investigate the biologic relationship of EAT with coronary plaque, we sought to explore the relationship between histological findings of EAT, represented by the amount of macrophages and vascularity, and CT-based high-risk characteristics of coronary plaques.
Materials and methods

Study participants
This was a post hoc analysis of our previous study [9] . Between July 2013 and March 2017, 67 patients underwent CCTA for the evaluation of CAD in preparation for elective cardiac surgery and EAT specimens were taken during surgery. We retrospectively reviewed these patients and identified 34 with one or more coronary plaques containing noncalcified components verified by CCTA for further analysis in this study. Twenty-five patients had undergone coronary artery bypass graft (CABG) surgery and nine non-CABG cardiac surgery (aortic valve repair, n = 5; mitral valve repair, n = 4). We excluded patients receiving hemodialysis, and who had previously undergone percutaneous coronary intervention or cardiac surgery. The selected patients' clinical and demographic characteristics, including coronary risk factors and statin use, were recorded.
The ethics committee of our hospital approved the study protocol. We had obtained written informed consent from all participants. The protocol has been published in the Japan UMIN Clinical Trial Registry (ID: UMIN000010654).
Cardiac CT protocol
All 34 patients underwent cardiac CT imaging by a 320 detector row CT scanner (Aquilion ONE; Toshiba Medical Systems, Otawara, Japan) within 1 month prior to cardiac surgery. Patients with a resting heart rate ≥ 60 beats/min received 40 mg of metoprolol orally 60 min before the CT examination; All received 0.3 mg nitroglycerin sublingually just before scanning. A plain scan was undertaken to measure coronary calcium score (CCS) according to the Agatston method (slice thickness 3.0 mm; maximum tube current 270 mA; tube voltage 120 kV). The dataset for CCTA was acquired after administration of 30-50 ml (0.6-0.7 ml/kg) of contrast medium (Iopamidol, 370 mg I/ ml, Bayer Healthcare, Berlin, Germany), under retrospective electrocardiography gating. We acquired datasets for CCTA using the HeartNAVI ® system (collimation 320 × 0.5 mm; tube current 350-580 mA; tube voltage 120 kV; Toshiba Medical Systems), providing the best number of acquired heart beat data and temporal resolution optimized according to the heart rate during scanning. The effective radiation dose for CCTA estimated using the dose-length product was 8 ± 4 mSv per patient [9] .
All reconstructed CT image data were analyzed using an offline workstation (Advantage Workstation version. 4.2, GE Healthcare, Waukesha, WI, USA).
Measurement of VAT area, EAT volume, and EAT density
According to the methods we have previously reported [9] [10] [11] [12] , two independent observers performed the quantification of VAT and EAT. The definition of VAT area was the intraperitoneal adipose tissue area with a CT density ranging from − 150 to − 50 Hounsfield units (HU) on plain CT images [13] , determined from an image at the level of the umbilicus using dedicated software (Virtual Place, AZE Inc., Tokyo, Japan). Epicardial adipose tissue was defined as adipose tissue surrounding the myocardium and limited by the epicardium with a density range between − 250 and − 30 HU on plain CT images [14] , and its area was quantified using the same software as for VAT area. Epicardial adipose tissue volume was measured by calculating the total sum of EAT areas from 1 cm above the left main coronary artery to the left ventricular apex on images taken at 1 cm intervals. Although differing in the density range of VAT and EAT, the above methods are traditionally used to quantify adipose tissue in clinical practice.
Additionally, the patient-based density of EAT was determined as follows. The densities of EAT were measured in three 1-mm 2 regions of interest (ROIs) around each the left anterior descending artery and right coronary artery, and the mean value of all ROIs was applied to each patient. Although the standard method to determine EAT density had not yet been established clinically, we used the value to examine its association with the histological findings of EAT.
Evaluation of coronary plaque characteristics on CCTA
Two independent observers evaluated all coronary segments > 2 mm in diameter on CCTA. The definition of non-calcified coronary plaque (NCP) was a low density mass > 1 mm 2 in area, located in the vessel wall, and clearly distinguishable from the contrast-enhanced coronary lumen and the surrounding pericardial tissue [15] . Coronary lesion containing both NCP and coronary calcium deposits (a structure with a CT density > 130 HU) was also included in NCP. If the initial assessment of the definition of NCP differed between the two independent observers, agreement was reached by consensus.
We performed analyses of NCP characteristics based on techniques used in our previous CCTA studies [10, 11, 16, 17] . Each NCP detected on CCTA was evaluated with the minimum CTD and vascular RI. The CTD was determined by placing at least five 1-mm 2 ROIs in each NCP and documenting the lowest average value of all ROIs. The RI was calculated based on measurements of the cross-sectional vessel areas (in mm 2 ) at each NCP site of maximum vessel area and each proximal reference site of the same coronary artery. Low-density NCP was defined as lesions with CTD < 39 HU, positive remodeling (PR) was defined as RI > 1.05; low-density NCP with PR was determined to be two-characteristic plaque (2-CP).
Patients were then divided into two groups based on the presence or absence of 2-CP on CCTA. We also used the minimum CTD and maximum RI per patient for a patientbased quantitative analysis of NCP characteristics evaluated on CCTA.
Collection and histological analysis of EAT samples
Two samples of EAT [one adjacent to the left anterior descending artery (left EAT), another adjacent to the right coronary artery (right EAT)] were obtained during each operation. Both samples were removed within 1 cm of the coronary arteries, and the size of each sample was generalized (5 mm in longest diameter). These samples were immediately analyzed immunohistochemically.
The methods for histological analysis of EAT samples were given in detail in our previous report. Briefly, after adipose tissue samples were fixed in 10% buffered formalin and embedded in paraffin, all immunohistochemical staining of the 5-μm sections was performed using a Dako Envision Kit (Dako, Carpinteria, CA, USA). Primary antibodies against CD68 (1:100, clone KP-1; Dako, Glostrup, Denmark) and CD31 (1:100, clone JC70A; Dako, Glostrup) were used to stain for macrophages and endothelial cells, respectively. Sections were then incubated with peroxidase-labeled anti-mouse IgG and substrate-chromogen solution, and counterstaining was done with 0.1% hematoxylin.
Histology images were analyzed at a magnification of 400×. To quantify the amount of macrophages in EAT, CD68-positive individual cells were counted in three random high-power fields (one field corresponded to a circle of radius 250 µm) in each left and right EAT specimen, and the summed number of the cells was reported for each patient. For vascularity in EAT, CD31-positive microvessels, rather than individual cells, in three random high-power fields were counted in each left and right EAT specimen, and the summed number of the microvessels was reported for each patient. Although this method had a limitation in quantifying the cells and microvessels universally in the whole EAT, it was used in our previous report [9] , and applied here as a series of the analysis.
Statistical analysis
Coronary calcium score is expressed as the median (interquartile range) and other continuous variables are expressed as the mean ± standard deviation. Categorical variables are presented as numbers of patients (proportion, %). Student's t test or the Mann-Whitney test was used for group comparisons of continuous variables. The normality of continuous variables was tested by Shapiro-Wilk test. Group comparisons of binary variables were performed using Pearson's Chi-squared test. Inter-observer reproducibility of EAT volume, and minimum CTD and maximum RI per patient was determined by calculating Pearson's correlation. Potential correlations between EAT parameters on CT (volume and density) and histological findings of EAT were assessed using Pearson's correlation. Linear regression was used for univariate and multivariate analyses and the value of standardized β was calculated to evaluate the relationships between clinical factors and the amounts of EAT macrophages or vascularity. Multivariate analyses were adjusted for potential confounders based on previous reports: age, sex, statin use, CABG versus non-CABG surgery, VAT area, EAT volume, coronary risk factors and CCS. p values < 0.05 were considered statistically significant. All statistical analyses were performed with JMP 11 statistical software (SAS Institute Inc. Cary, NC, USA).
Results
Baseline characteristics
We identified a total of 74 NCPs on CCTA in the cohort of 34 patients; the median number of NCPs per patient was 2 (range 1-5). Eleven patients had one NCP and the other 23 had ≥ 2 NCPs. Nineteen patients had at least one 2-CP 1 3 on CCTA and 15 had no 2-CPs. The clinical characteristics of the patient cohort, and those of the 2-CP and non-2-CP groups, are shown in Table 1 . Patients with 2-CP had higher frequency of dyslipidemia (p = 0.020), statin use (p = 0.0019), and scheduled CABG surgery (p = 0.018). They had a lower level of serum high-density lipoprotein (p = 0.03). There were no other significant differencesincluding CCS-between the groups. Figure 1 shows clinical adipose tissue quantities in the 2-CP and non-2-CP groups. There were no significant differences in VAT area (98 ± 43 in the 2-CP group compared with 86 ± 46 in the non-2-CP group, p = 0.44) or EAT volume (143 ± 66 in the 2-CP group compared with 147 ± 60 in the non-2-CP group, p = 0.88). Notably, there was a wide range of EAT volume in both groups.
Relationships between EAT histology and EAT parameters or NCP characteristics on CCTA
Inter-observer agreement for EAT volume was excellent (r = 0.95, p < 0.001). As shown in Fig. 2 Inter-observer agreements for minimum CTD and maximum RI per patient were good (r = 0.87, p < 0.001, and r = 0.80, p < 0.001, respectively). Figure 3 shows the correlations between EAT histology and patient-based NCP characteristics. There was no relationship between minimum CTD of NCPs and EAT macrophages (r = − 0.24, p = 0.17) or vascularity (r = − 0.17, p = 0.34). On the one hand, although the data plots were scattered, maximum RI had a significant positive correlation with EAT macrophages (r = 0.37, p = 0.030). The correlation of maximum RI with EAT vascularity did not reach significance (r = 0.31, p = 0.072). Figure 4 shows the amounts of EAT macrophages and vascularity in the 2-CP and non-2-CP groups. Patients with 2-CP had significantly more extensive EAT macrophages (85 ± 38 compared with 45 ± 22 in the non-2-CP group, p = 0.0005) and greater vascularity (62 ± 33 compares with 37 ± 19 in the non-2-CP group, p = 0.013), but there were substantial overlaps of the distributions of EAT macrophages and vascularity in the two groups. Table 2 shows the results of linear regression analysis to examine clinical factors related to the amounts of EAT macrophages and vascularity. Univariate analysis revealed that the presence of 2-CP on CCTA correlated significantly with increased EAT macrophages (β = 0.55, p = 0.0008) and vascularity (β = 0.42, p = 0.013), while the scheduled CABG (β = 0.12, p = 0.49 for macrophages; β = − 0.15, p = 0.40 for vascularity) and CCS (β = − 0.29, p = 0.097 
Relationships between EAT histology and presence of 2-CP on CCTA
Discussion
In patients with one or more NCPs verified by CCTA, we assessed the relationship between the inflammatory and angiogenic properties of EAT on histology, EAT volume, and NCP characteristics on CCTA. In this study, we defined NCP as coronary plaque containing non-calcified components, and found the following: (1) the amounts of EAT macrophages and vascularity did not correlate with EAT volume; (2) the amount of EAT macrophages correlated with formation of multiple NCPs; (3) the amount of EAT macrophages was more likely to be elevated in patients having NCP with higher RI; and (4) the amounts of EAT macrophages and vascularity independently correlated with the presence of 2-CP, defined by CTD < 39 HU and RI > 1.05. These results suggest that the biologic activities of EAT are associated with coronary plaque pathogenesis and vulnerability, and strengthen the theory that EAT has a pathophysiologic role in coronary atherosclerosis.
Several reports have underlined the significance of EAT volume measured with non-contrast enhanced CT. A positive relationship has been observed between EAT volume and CCS [18, 19] , but other-more recent-reports to the contrary [20, 21] mean that the clinical significance of EAT volume is a matter of lively academic debate. We have reported that high EAT volume is associated with the presence of NCP on CCTA in patients with a CCS of zero, which should represent the early phase of coronary atherosclerosis [12] . While EAT volume is reportedly associated with new development of non-calcified coronary plaque in asymptomatic individuals [22] , its clinical significance may vary, or may decrease as CAD progresses. The subjects enrolled in our study were mostly scheduled for CABG and would likely have been in the advanced stages of CAD, but had a wide range of EAT volumes irrespective of the presence of 2-CP. The lower impact of EAT volume on coronary atherosclerosis in our cohort might be a consequence of the patients' demographic and clinical characteristics.
Based on our previous results [16] , we defined low density NCPs as lesions with a minimum CTD < 39 HU and PR as an RI > 1.05 on CCTA. With this definition, we previously reported a higher prevalence of NCPs with high-risk characteristics in patients with acute coronary syndrome compared with those with stable CAD [17] . We and others have reported that identification of NCPs with low CTD and PR on CCTA provides additional prognostic information for the prediction of future coronary events [8, 23] . Thus, CCTA has considerable potential to detect 'vulnerable' plaques. Furthermore, we previously reported that EAT volume correlated with CT-based high-risk characteristics of NCPs (CT density < 39 HU and RI > 1.05) [11] . The other report demonstrates that EAT thickness measured by echocardiography is associated with high-risk characteristics of coronary plaques on CCTA [24] . However, the relationship between histological findings of EAT and coronary plaque characteristics assessed by CCTA has not been examined before.
An inflammatory profile in EAT has attracted interest and been reported [25] . Baker et al. suggested that a pathogenic molecular profile of EAT could be a result of macrophage infiltration [26] . Hirata et al. reported that the ratio of M1 to M2 macrophages in the EAT of patients with CAD differed significantly from that of non-CAD patients [27] . According to these previous reports, the accumulation and activation of macrophages in EAT as a result of a pro-inflammatory signaling pathway presumably plays a role in the process of CAD. Adipose tissue is highly adaptive to its environment and can expand rapidly when an appropriate blood supply is provided by new vessels. Neoangiogenesis is, therefore, considered a rate-limiting step for remodeling of adipose tissue, and new adipocytes tend to be highly angiogenic [7] . Thus, the inflammatory and angiogenic properties of EAT are considered to be key factors in terms of its biologic contribution to CAD. In this study, we demonstrated that biologic activities in EAT, represented by the amounts of macrophages and vascularity, might influence NCP formation, and correlated with the presence of 2-CPs defined by a CTD < 39 and an RI > 1.05 on CCTA. Our results suggest that EAT biology plays an important role in coronary plaque pathogenesis from a clinical perspective. However, the substantial overlaps of the EAT histological findings between the 2-CP and non-2-CP groups should be interpreted with caution.
Study limitations
First, the sample size was small and the participants mostly underwent CABG (so mostly had more advanced CAD), which may have resulted in selection bias and limited the generalizability of our findings. Further clinical investigations in more subjects are needed. Second, CD31 staining cannot strictly differentiate mature from immature small vessels in EAT, and thus cannot detect pure angiogenesis. This may explain why our histological assessment of vascularity did not correlate with NCP characteristics, while macrophages did (Fig. 3 ), but we judge that the difference in EAT vascularity between the groups (Fig. 4 ) was most likely due to emerging small vessels. Third, this study did not examine changes in macrophage polarity; further investigation, such as quantitative assessment of M1 and M2 macrophage phenotypes, will be necessary to improve our understanding of EAT inflammation. In addition, the lack of biomarker analysis in EAT is a significant limitation. Quantification of pro-inflammatory cytokines, such as monocyte chemotactic protein-1, tumor necrosis factor-α and interleukin-6, may help to illuminate the mechanisms of cross-talk between diseased EAT and coronary plaque. Fourth, beam hardening caused by severe calcification may increase the CT densities of NCPs, and contrast density within the coronary lumen may have an influence on the density of plaques. The RI measurement is based on the comparison of vessel area between NCPs and reference sites, which may be less susceptible to image artifacts. This might explain some of the differences in the relationships between EAT histological features when NCPs are assessed by CTD and RI (Fig. 3) . Although we have focused on coronary plaques containing non-calcified components which define CT-based high-risk characteristics in this study, calcified coronary plaques should be included to comprehensively assess the association + microvessels in six random high-power fields (x400) of EAT samples were 37 and 36, respectively between EAT histology and coronary plaque composition and burden.
Finally, although our data indicated that there were significant relationships between diseased EAT and coronary artery plaque, we did not demonstrate mechanistical effects of EAT biology on coronary plaque characteristics. A methodological approach using experimental animal models might be useful to elucidate them. In addition, there are no imaging tools available that can visualize diseased EAT. We found no correlation between EAT parameters on CT (volume and density) and histological findings of EAT in this study. Further studies are needed to evaluate diseased EAT in vivo, and to identify an effective means of reducing EAT pathogenicity.
Conclusions
We found that EAT inflammation and vascularity independently correlated with the presence of NCP with highrisk characteristics assessed on clinical CT images. Our results provide additional evidence to support a biologic relationship of EAT with coronary atherosclerosis, and emphasize the importance of further investigation of EAT pathogenicity.
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